Showing results (971-980 of 1,009) with videos related to

Sort By:
Pageof 101
Cancer|December 7, 2017
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemiaGail J Roboz, Hagop M Kantarjian, Karen W L Yee, et al.
Applied Vegetation Science|March 31, 2017
A higher-level classification of the Pannonian and western Pontic steppe grasslands (Central and Eastern Europe)Wolfgang Willner, Anna Kuzemko, Jürgen Dengler, et al.
Therapeutic Advances in Medical Oncology|July 25, 2026
Clinical management and outcomes of relapsed NSCLC after chemoradiotherapy and durvalumab consolidation: real-world evidence from GermanyGeorg Evers, Franziska Glanemann, Maximilian Webendörfer, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune DiseasesPeter Blomgren, Jayaraman Chandrasekhar, Julie A Di Paolo, et al.
Acta Neuropathologica|September 8, 2021
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomasElmar Kirches, Felix Sahm, Andrey Korshunov, et al.
Oncotarget|April 15, 2015
ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variabilityMatthias Scheffler, Anne Schultheis, Cristina Teixido, et al.
Hypertension (Dallas, Tex. : 1979)|December 28, 2017
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing AdenomaBritta Heinze, Carmina T Fuss, Paolo Mulatero, et al.
The Lancet. Oncology|August 29, 2017
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trialHagop M Kantarjian, Gail J Roboz, Patricia L Kropf, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Chronic Myelogenous Leukemia, Version 1.2014Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
EMBO Molecular Medicine|March 5, 2015
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myelomaKathrin Philipp-Abbrederis, Ken Herrmann, Stefan Knop, et al.
Pageof 101